scholarly journals Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry

2021 ◽  
Vol 49 (8) ◽  
pp. 630-640
Author(s):  
Cihan Altın ◽  
◽  
Caner Topaloğlu ◽  
Nurullah Çetin ◽  
Onur Dalgıç ◽  
...  
Keyword(s):  
Stroke Prevention ◽  
Real Life

scholarly journals Stroke Prevention in Atrial Fibrillation — The Use of NOACs in Everyday Clinical Practice

2015 ◽  
Vol 10 (2) ◽  
pp. 76
Author(s):  
Gheorghe-Andrei Dan ◽  
Adrian Catalin Buzea ◽  
◽  
Keyword(s):  
Atrial Fibrillation ◽  
Stroke Prevention ◽  
Large Scale ◽  
Oral Anticoagulants ◽  
Real Life ◽  
Everyday Clinical Practice ◽  
New Class ◽  
Antithrombotic Efficacy ◽  
Randomised Controlled ◽  
Near Future

Non-antivitamin K oral anticoagulants (NOACs) have recently emerged as a new class of antithrombotic drugs. Four large-scale, randomised controlled trials (RCT) accredited dabigatran, rivaroxaban and edoxaban with evident advantages for stroke prevention in atrial fibrillation (AF) compared with warfarin. The superiority concerns not only the manageability but also the antithrombotic efficacy and safety. Aspects of real-life clinical experience with NOAC for stroke prevention in AF are analysed in an attempt to underline some practical differences. If at present the individualisation of the NOAC class drugs is still a subject of debate it is probable that in the near future we will be able to adapt the drug and dosages to individual patient’s profile.

SECONDARY STROKE PREVENTION IN THE VERY ELDERLY IN REAL LIFE: PP.4.139

2010 ◽  
Vol 28 ◽  
pp. e90
Author(s):  
L Brescacin ◽  
C Alonzo ◽  
MC Zurru ◽  
S Brienza ◽  
F Ortega ◽  
...  
Keyword(s):  
Stroke Prevention ◽  
Real Life ◽  
Secondary Stroke Prevention ◽  
Very Elderly

scholarly journals REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation — The RELIEF study

2016 ◽  
Vol 203 ◽  
pp. 882-884 ◽  
Author(s):  
Craig I. Coleman ◽  
Matthias Antz ◽  
Birgit Ehlken ◽  
Thomas Evers
Keyword(s):  
Atrial Fibrillation ◽  
Stroke Prevention ◽  
Real Life

scholarly journals Real life efficacy and safety of rivaroxaban for stroke prevention in atrial fibrillation: updated results of the prospective NOAC registry (NCT01588119)

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P4870-P4870 ◽  
Author(s):  
J. Beyer-Westendorf ◽  
F. Ebertz ◽  
V. Gelbricht ◽  
K. Foerster ◽  
L. Tittl ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Stroke Prevention ◽  
Real Life ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document